Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.

Guzmán L, Depix MS, Salinas AM, Roldán R, Aguayo F, Silva A, Vinet R.

Diagn Pathol. 2012 Jul 20;7:87. doi: 10.1186/1746-1596-7-87.

2.

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.

Cancer Res. 2002 Apr 15;62(8):2370-7.

3.

Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.

Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S.

Clin Cancer Res. 2005 Apr 1;11(7):2466-70.

4.

Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.

Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L.

Cancer Res. 2002 Jan 15;62(2):351-5.

5.

Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.

Honorio S, Agathanggelou A, Schuermann M, Pankow W, Viacava P, Maher ER, Latif F.

Oncogene. 2003 Jan 9;22(1):147-50.

PMID:
12527916
6.

[Aberrant promoter methylation of tumor suppressor genes in serum from lung cancer patients: frequency and correlation with clinicopathological characteristics].

Zemaitis M, Rieger N, Fischer JR, Sakalauskas R, Malakauskas K, Lahm H.

Medicina (Kaunas). 2005;41(2):123-31. Lithuanian.

8.

Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.

Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K, Kozuki T, Aoe M, Kiura K, Ueoka H, Tanimoto M.

Clin Cancer Res. 2005 Feb 1;11(3):1219-25.

9.

Aberrant promoter hypermethylation in serum DNA from patients with silicosis.

Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.

Carcinogenesis. 2008 Sep;29(9):1845-9. doi: 10.1093/carcin/bgn169. Epub 2008 Jul 16.

PMID:
18632757
10.

Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure.

Scesnaite A, Jarmalaite S, Mutanen P, Anttila S, Nyberg F, Benhamou S, Boffetta P, Husgafvel-Pursiainen K.

Mutagenesis. 2012 Jul;27(4):423-9. doi: 10.1093/mutage/ger092. Epub 2012 Jan 4.

PMID:
22217548
11.

Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.

Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC.

Cancer. 2007 Nov 1;110(9):2019-26.

12.

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.

Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D.

J Natl Cancer Inst. 2006 Jul 19;98(14):996-1004.

PMID:
16849682
13.
14.

Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking.

Georgiou E, Valeri R, Tzimagiorgis G, Anzel J, Krikelis D, Tsilikas C, Sarikos G, Destouni C, Dimitriadou A, Kouidou S.

Eur J Cancer Prev. 2007 Oct;16(5):396-402.

PMID:
17923809
15.

Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.

Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.

PMID:
19695681
16.

Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.

Gömöri E, Pál J, Kovács B, Dóczi T.

Diagn Pathol. 2012 Jan 20;7:8. doi: 10.1186/1746-1596-7-8.

17.

Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer.

Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, Moon CS.

Clin Cancer Res. 2004 Apr 1;10(7):2284-8.

18.

Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.

Hubers AJ, Heideman DA, Herder GJ, Burgers SA, Sterk PJ, Kunst PW, Smit HJ, Postmus PE, Witte BI, Duin S, Snijders PJ, Smit EF, Thunnissen E.

J Clin Pathol. 2012 Jun;65(6):541-5. doi: 10.1136/jclinpath-2012-200712. Epub 2012 Mar 29.

PMID:
22461647
19.
20.

Aberrant methylation in non-small cell lung cancer.

Suzuki M, Yoshino I.

Surg Today. 2010 Jul;40(7):602-7. doi: 10.1007/s00595-009-4094-6. Epub 2010 Jun 26. Review.

PMID:
20582509

Supplemental Content

Support Center